Our Services

The early pregnancy assessment is typically conducted between 6 – 10 weeks of pregnancy. 

The primary objectives of the dating and viability scan are to: 

• Assess the viability of the pregnancy. 
• Determine the gestational age of the pregnancy. 
• Identify the number of embryos present. 
• Determine the position of the pregnancy and ensure it is progressing normally within the uterus. 

The early pregnancy assessment is recommended for women experiencing pain and/or bleeding during pregnancy, as well as those with a history of miscarriages or ectopic pregnancies. 

Recommended preparation: 

It is advisable to have a moderately full bladder, as it helps in positioning the uterus for better visualisation of the baby. We recommend emptying your bladder one hour before the appointment and drinking two standard glasses of water. Please refrain from using the toilet until after the scan. 

We prioritise patient comfort and encourage individuals to let our reception staff know if you are uncomfortable while waiting for your scan. 

We love seeing members of your family join you for the scan, but please keep in mind that it is a diagnostic ultrasound, and the sonographer will need to concentrate on obtaining accurate images of your baby. 

The First Trimester scan is requested by doctors for a number of reasons. It is useful for dating a pregnancy if a woman cannot recall the date of their last period, if she has an irregular menstrual cycle or for women who may have conceived whilst breastfeeding or soon after stopping contraception. We measure the size of the fetus which enables us to calculate the EDD (expected date of delivery). 

The first trimester scan is also used to diagnose multiple pregnancies (approximately 2% of natural conceptions and 10% of assisted conceptions result in a multiple pregnancy). If a multiple pregnancy is diagnosed this scan can also help determine if both/all babies are developing normally and if they have the same placenta, which can lead to problems further along in the pregnancy. Closer monitoring would be recommended in these cases.

Major physical abnormalities can sometimes be seen in an ultrasound examination at this gestation, which is why a first trimester scan is always recommended to patients, even if NIPT has returned as a low-risk result. 

The combined “First Trimester Screen” takes the results from the scan (findings of nuchal translucency thickness, nasal bone, blood flow through the fetal heart and ductus venosus and fetal abnormalities) and results from the blood test (PAPP-A, BhCG and PlGF) and combines them with the biological mothers age to give an individual calculated chromosomal risk for the pregnancy. A risk for other factors will also be calculated, such as risk for pre-eclampsia, fetal growth restriction and spontaneous delivery before 34 weeks.

If a high -risk result is reported at the First Trimester Combined Screening, parents will receive full counselling from one of our specialists on the significance of these risks and the options they have for further testing, including invasive testing with CVS or Amniocentesis.

Your referring Doctor should provide you with a request for first trimester ultrasound at MFAC and a first trimester blood request form which should include: PAPP-A, BhCG and PlGF. This blood test should be collected 4-6 days before your booked ultrasound, so that the results are available to our clinicians to provide you with the Combined First Trimester Screen report in a timely manner.

Recommended preparation: 

It is advisable to have a moderately full bladder, as it helps in positioning the uterus for better visualisation of the baby. We recommend emptying your bladder one hour before the appointment and drinking two standard glasses of water. Please refrain from using the toilet until after the scan. We prioritise patient comfort and encourage individuals to let our reception staff know if you are uncomfortable while waiting for your scan. 

We love seeing members of your family join you for the scan, but please keep in mind that it is a diagnostic ultrasound, and the sonographer will need to concentrate on obtaining accurate images of your baby.

Chorionic Villus Sampling (CVS)

CVS is a procedure that examines chorionic villi (placental tissue) and is available if indicated, to patients between 12-14 weeks of pregnancy. The cells in the placenta typically mirror the chromosomes of the fetus, making CVS an effective tool for identifying fetal chromosomal abnormalities.

What to expect: 

An ultrasound is performed to confirm the dates of the pregnancy and check the position of the fetus and placenta. A local anaesthetic is then applied to the mothers abdomen and under ultrasound guidance, a fine needle is passed through the abdomen and into the placental tissue. A small sample of the chorionic villi is collected (which only takes approximately 60 seconds). The needle is observed constantly and carefully during the procedure using ultrasound. After the needle is safely removed, our specialists will repeat an ultrasound scan to ensure the fetal heartbeat is normal. 

Result timeline: 

The FISH (Fluorescence In-Situ Hybridisation) analysis, targeting the five main chromosomes associated with aneuploidy, yields a result within 2-3 days. Long term culture chromosome analysis requires cell growth time and typically provides results within 2 weeks. Our MFAC specialists will promptly communicate these results and discuss necessary counselling and management.  

Risks and post-procedure aftercare: 

Our specialists will provide a comprehensive risk assessment relative to potential chromosome abnormalities. The risk of miscarriage due to CVS is less than 1%. After the CVS, patients may experience mild spotting and cramping in the 24-28 hours post-procedure. These symptoms typically resolve without impact on the baby or pregnancy. Should symptoms persist or new abnormalities arise, please be in touch with MFAC. It is recommended to rest and avoid strenuous activity post procedure. Medical and carers certificates are available upon request. 

Amniocentesis: 

An amniocentesis procedure is an invasive diagnostic procedure that examines the cells in the amniotic fluid from around the baby. If indicated, amniocentesis is available between 15-19 weeks of pregnancy. The cells in the amniotic fluid originate from the baby and therefore the chromosomes present in the cells are the same as those of the baby.

What to expect: 

An ultrasound is first performed to check the position of the fetus and placenta. A local anaesthetic is then applied to the mother’s abdomen and under ultrasound guidance, a fine needle is passed through the abdomen and into a pocket of fluid. The pocket of fluid is a safe distance away from the fetus and placenta.  A small sample of fluid is collected (approximately 20-30mL). The withdrawal process takes about 60 seconds. After the needle is safely removed, our specialists will repeat an ultrasound scan to ensure the fetal heartbeat is normal.

Result timeline:

The FISH (Fluorescence In-Situ Hybridisation) analysis, targeting the five main chromosomes associated with aneuploidy, yields a result within 2-3 days. Long term culture chromosome analysis requires cell growth time and typically provides results within 2 weeks. Our MFAC specialists will promptly communicate these results and discuss necessary counselling and management.  

Risks and post-procedure aftercare:

Our specialists will provide a comprehensive risk assessment relative to potential chromosome abnormalities. The risk of miscarriage due to amniocentesis is less than 1%. After the amniocentesis, patients may experience mild spotting and cramping in the 24-28 hours post-procedure. These symptoms typically resolve without impact on the baby or pregnancy. Should symptoms persist or new abnormalities arise, please be in touch with MFAC. It is recommended to rest and avoid strenuous activity post procedure. Medical and carers certificates are available upon request. 

The morphology scan is typically conducted between 18-20 weeks of pregnancy. The ultrasound is a comprehensive examination aimed at evaluating various aspects of fetal development. 

During the scan, the sonographer will assess each aspect of the fetal body including the brain, face, spine, heart, stomach bowel, kidneys, and limbs. Additionally, the scan will determine the placental position, evaluate amniotic fluid level, and monitor fetal growth. 

Should any anomalies be detected, our team will thoroughly discuss the findings with the parents and provide them with the opportunity for further counselling and consideration of further testing. 

If you wish to know the gender of your baby, please inform the sonographer. It is important to note that determining the gender may not always be possible due to multiple factors including the position of the baby. Please be aware that the assessment of the baby’s gender is not 100% accurate. Alternatively, if you would prefer not to know the gender, please let the sonographer know before the scan commences.   

We love seeing members of your family join you for the scan, but please keep in mind that it is a diagnostic scan, and the sonographer will need to concentrate on obtaining accurate images of your baby. 

The growth and wellbeing scan is typically conducted in the third trimester of pregnancy. While some obstetricians recommend this scan for all pregnant women, others reserve it for those with a history of complications such as preeclampsia, fetal growth restriction, diabetes, or previous stillbirth, as well as those who encounter a problem during their current pregnancy. 

The growth and wellbeing scan aims to: 

• Provide an estimate of fetal weight by measuring the baby’s head, abdomen, and thigh bone. 
• Evaluate the position and appearance of the placenta. 
• Measure the quantity of amniotic fluid. 
• Assess blood flow to both the placenta and baby through colour Doppler ultrasound. 
• Monitor the baby’s movement.

In addition to routine ultrasound, MFAC offers tertiary and second opinion obstetric scans to ensure thorough evaluation and peace of mind for expectant mothers. There are several reasons why your doctor may refer to us to seek a second opinion including: 

• If an abnormality has been identified
• In cases where a previous scan indicated a potential abnormality but was inconclusive
• When a previous scan was reported as incomplete or certain views of the baby’s anatomy was not obtained 
• Seeking reassurance 

If an abnormality has been identified, our MFAC specialists offer comprehensive counselling and will talk you through any implications for you and your baby. MFAC offers video conferencing with esteemed obstetricians and maternal-fetal medicine specialists or the choice to travel to Canberra for further opinion and management.  

MFAC provides a comprehensive range of services tailored to the unique needs of multiple pregnancies. Expecting a multiple pregnancy is an exciting journey, but it also comes with unique considerations for both you and your babies. At MFAC we understand the importance of careful and detailed assessment during multiple pregnancies.

All of MFAC’s obstetric ultrasound examinations cater for multiple pregnancies. If you have a multiple pregnancy, it is important to have ultrasounds performed at key timelines to monitor your health, and the well-being of your babies. 

Key ultrasounds recommended for multiple pregnancies include: 

Dating scan (6 – 10 weeks) 

Date the pregnancy, assess the viability of the pregnancy as well as identify the chorionicity of the twin pregnancy. 

Nuchal translucency scan (12 – 13 weeks) 

Assess the baby’s early anatomy and nuchal translucency. 

Morphology scan (18 – 20 weeks) 

A comprehensive evaluation of the baby’s anatomical structures and development. 

Regular growth and well-being scans 

Monitor the babies ongoing development including fetal growth parameters, amniotic fluid levels and placental function. 

At MFAC, we can facilitate the collection of your VCGS Prepair Genetic Carrier Screening. No referral or request is required from your GP or specialist, we handle everything for you!

Genetic Carrier Screening involves the self-collection of a simple mouth saliva swab that is taken from you +/- your reproductive partner to determine if you are carriers for a genetic condition.

Having 1 fault copy and 1 working copy of a gene is called being a carrier. Being a carrier usually does not affect your health.

Most people who are identified as being a carrier have no family history of the condition.

If you and your reproductive partner are both carriers for the same genetic condition, this means you usually have a 1 in 4 chance (25%) of having a child born with that same condition. Knowing this information can be very useful when starting to plan a family.

MFAC handles the whole process for you including the request form, assistance with collection of the swab, handling the sending of the sample/s to VCGA and the processing and notifying of results to all patients. All high-risk results will be followed up by one of our specialist Obstetricians and free genetic counselling services are also available to patients through VCGS, if patients choose to.

There are 3 different test options available for Prepair Genetic Carrier Screening to consider:

• Prepair 3 is the standard screening test which looks at the 3 most common, inherited genetic conditions in our population: Cystic Fibrosis (CF), Fragile X Syndrome (FXS) and Spinal Muscular Atrophy (SMA) (Prepair 3 is covered by Medicare for eligible patients) Results typically take 2-4 weeks from when the lab receives the sample

• Prepair 500+ looks at over 500 genes, including genes for CF, FXS and SMA ($975 per couple) Results typically take 6-8 weeks from when the lab receives the sample

•Prepair 1000+ is the most comprehensive test that looks at over 1000 genes associated with more than 750 conditions, including CF, FXS and SMA ($1,500 per couple) Results typically take 6-8 weeks from when the lab receives the sample

Prepair is a “once in a lifetime” test, meaning as long as you have not had this test performed before, the laboratory fees for the 3 standard tests (CF, FXS & SMA) are bulkbilled.

Biological female usually screened first for the Prepair 3 option. Reproductive partner is only screened if the female is a carrier for CF or SMA. (With this process, both tests are bulk-billed if eligible)

**If the male reproductive partner would like to be tested for Prepair 3 at the same time, to avoid waiting/delay in results, $389 is applicable for the Prepair 3 test for the male partner – invoice directly by VCGS.

There is a small $50 admin and processing fee for each patient (regardless of test option), payable at Moruya Fetal Assessment Cantre at the time of collection.

Follow the link below to book your Prepair Genetic Carrier Screening swab in today through HotDoc (each patient will require their own booking, but can be made back to back).

A common procedure used to assess pelvic organs is a pelvic ultrasound. Common reasons for a pelvic ultrasound include abnormal bleeding, abdominal pain, Polycystic Ovaries, and fibroids. A pelvic ultrasound is a tool used to visualise the ovaries, uterus lining and surrounding structures as well as identify any anomalies such as cysts or fibroids. 

Transabdominal ultrasound: 

The ultrasound begins with gel being applied and an ultrasound probe being placed on the lower abdomen. Typically, the uterus and ovaries come into view during the procedure. Additionally, any pelvic masses, including those extending higher into the abdomen can be identified. 

Recommended preparation: 

It is recommended to have a moderately full bladder, which allows better imaging of the anatomy of the uterus. One hour before your appointment, please empty your bladder completely then drink 2 standard glasses of water. Please refrain from going to the toilet until after your scan. We prioritise patient comfort and encourage individuals to let our reception staff know if you are uncomfortable while waiting for your scan.

Transvaginal ultrasound:

Additional to a transabdominal ultrasound, a transvaginal (internal) ultrasound will be offered in most cases to enhance visualisation of the ovaries and uterus as the transducer can be positioned in closer proximity to these structures. You will be asked to empty your bladder. With your consent, a small, narrow ultrasound transducer covered in a disposable sterile protective cover is gently placed into the vagina. 

Endometriosis is a prevalent medical condition that affects many women. Endometriosis occurs when tissue similar to the lining of the uterus (endometrium) grows outside the uterus, such as on the ovaries, uterine muscle or other areas of the pelvis. There are two main types of endometriosis including superficial lesions and DIE. A detailed endometriosis ultrasound is known as a Deep Infiltrative Endometriosis Scan (DIE scan). While a pelvic ultrasound can identify lesions and cysts, detecting severe DIE often requires a specialised scan which enables accurate diagnosis and treatment planning. 

Recommended preparation:

It is recommended to have a moderately full bladder, which allows better imaging of the anatomy of the uterus. One hour before your appointment, please empty your bladder completely then drink 2 standard glasses of water. Please refrain from going to the toilet until after your scan. We prioritise patient comfort and encourage individuals to let our reception staff know if you are uncomfortable while waiting for your scan. It is also recommended to be fasted from food for 8 hours before your ultrasound. Fasting ensures there is minimal gas in the bowel to properly assess any adhesions and sliding signs of the pelvic organs. 

Saline infusion sonohysterography (SHG or SIS) is a procedure used to identify any abnormalities within the uterus and endometrial cavity. The procedure involves visualising the uterus and its cavity using ultrasound while sterile saline is gently introduced into the uterine cavity. 

Conversely, HyCoSy ultrasound utilises contrast media to assess the patency of the fallopian tubes. 

SHG/HyCoSy is typically conducted for various reasons including abnormal uterine bleeding, infertility investigations, recurrent miscarriages, congenital uterine abnormalities, pre and post operative assessments of the uterine cavity, suspected intrauterine adhesions and further examination of abnormalities detected during regular ultrasound. It is important to note that SHG/HyCoSy ultrasound is not recommended for pregnant women, those suspected to be pregnant or individuals with an acute pelvic infection. 

SHG/HyCoSy is typically conducted during the early stages of the menstrual cycle, following menstruation (between day 5 – 12). The procedure commences with a transvaginal (internal) ultrasound examination. Subsequently, a speculum is inserted and a small narrow catheter is gently guided through the cervix into the uterine cavity. Throughout this process, the ultrasound examination continues while sterile saline is carefully instilled into the uterine cavity. The saline solution helps to create a clear outline of the uterine cavity, facilitating identification of abnormalities including endometrial polyps or intracavitary fibroids. Similarly, HyCoSy ultrasound allows to check for tubal patency. 

Potential risks and complications:

SHG/HyCoSy is generally considered a very safe procedure. Potential side effects may include cramping, spotting, and vaginal discharge. While pelvic infection is the most serious complication, it is rare, affecting less than 1% of cases. If you experience pain or fever one to two days after the procedure, it is important to contact your doctor promptly.

Recommended preparation: 

It is recommended to take 2 paracetamol (Panadol) and 2 ibuprofen (Nurofen) tablets 1 hour before the appointment. If you are sensitive to these medications, please be driven to and from the appointment. It is not required to have a full bladder, however, we will perform a urine pregnancy test prior to the procedure. 

MFAC provides appointments for comprehensive discussions on standard pregnancy screening and testing, along with the typical preparations for pregnancy. 

Additionally, we accommodate families with complex medical backgrounds that require specialised testing. We have the services of senior genetic counsellors and specialists to help facilitate appropriate counselling and testing.

At MFAC, we recognise the profound impact of pregnancy loss. We are committed to offering follow-up support to address potential causes and provide guidance for future pregnancies.

Patients will be informed of the scan results according to the referrer’s preferences. If a screening test yields a positive result, we will ensure the patient is fully informed and all available options are discussed and offered. We will always support the patients’ decisions, which may include additional testing including both non-invasive prenatal testing or invasive procedures such as CVS and amniocentesis in collaboration with the referring doctor. 

Non-Invasive Prenatal Testing (NIPT) is available to women who are over 10 weeks of pregnancy. It is a very simple and low-risk screening test in the form of a blood test that analyses the cell free DNA in the maternal blood.

At MFAC we offer a comprehensive NIPT package for our patients, which includes an early pregnancy assessment/viability scan and blood collection for NIPT, FTS and CMV screening (if applicable). Our NIPT blood collection is sent to VCGS (Victorian Clinical Genetic Services) through their Percept program. Percept is a genome wide NIPT that screens for conditions across all 23 pairs of chromosomes. This genome wide approach allows VCGS to detect the broadest range of chromosomal conditions, compared to standard NIPT tests (which usually only screen for Trisomy 13, Trisomy 18, Trisomy 21 and sex chromosome conditions).

It is important to note that NIPT is a screening test and is not diagnostic. We do have follow-up diagnostic testing options at MFAC if a high-risk result is reported. If a low-risk result is reported, this is reassuring and reduces the risk of chromosomal abnormalities to approximately 1 in 10,000.

The results from Percept NIPT usually take 7-10 days. There is a 2-4% chance of an inconclusive result, which can be discussed with our specialists. The results will go back to your referring Doctor, however the specialists at MFAC will contact a patient if a high-risk result is reported. Options for diagnostic testing will be discussed with the patient directly.

The VCGS Percept Request form can be downloaded HERE. Please provide to your referring Doctor to complete.

NIPT is a private test and unfortunately, not yet included in the Medicare Benefits Schedule. The total cost for the NIPT package through MFAC is $625. This includes access to our App with your ultrasound images and report.

Please contact MFAC to make a booking for the Percept NIPT Package.